Perlancia Peptides
Perlancia Peptides restricts purchases to individuals conducting laboratory or institutional research and at least 21 years old. By entering, you confirm you meet this requirement.
All products offered on this website are sold strictly as research chemicals for in-vitro laboratory research use only. They are not drugs, foods, cosmetics, dietary supplements or medical devices, and they are not intended for human or veterinary consumption, diagnostic use, or therapeutic use of any kind.
Selecting “No” will take you away from this website. This confirmation will be remembered on this device for 30 days.
The research peptide market has a documentation problem. Suppliers claim purity figures, print COA headers, and attach lab logos to product pages with varying degrees of rigor behind them. For a researcher selecting compounds for a study, that variance matters. A peptide at 92% purity is not the same reagent as one at 99%, and […]
Tissue repair and regenerative peptides represent a widely studied class of research compounds investigated for their interactions with cellular repair, extracellular matrix remodeling, and tissue regeneration pathways. Scientific interest in this class developed across several decades, beginning with research into endogenous tissue protective peptides and advancing through the characterization of synthetic compounds capable of interacting […]
SS-31, also designated elamipretide and known in earlier research literature under the designations MTP-131 and Bendavia, is a synthetic aromatic-cationic tetrapeptide belonging to the Szeto-Schiller family of mitochondria-targeted peptide research compounds. The compound was first described in the published scientific literature by Hazel Szeto and Peter Schiller during investigations into cell-permeable peptides capable of selectively […]
The research peptide supplier market has undergone significant disruption over the past two years. Vendor consolidations, voluntary shutdowns, and increased regulatory scrutiny have forced laboratories and independent researchers to re-evaluate their sourcing strategies mid-project. For researchers who built procurement workflows around established suppliers, these disruptions are more than an inconvenience. They represent a genuine threat […]
Introduction In peptide research, the quality of results depends heavily on the purity and identity of the compounds used. A Certificate of Analysis (COA) is the primary document that establishes whether a research peptide meets the standards required for reliable laboratory work. Yet COAs vary significantly across suppliers, and not all researchers are familiar with […]
Tirzepatide is a synthetic dual agonist peptide that acts at both the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide receptor (GIPR), two members of the class B G protein-coupled receptor family that play central roles in incretin-mediated regulation of insulin secretion and metabolic homeostasis. The compound was developed by Eli Lilly and Company […]
Thymosin Alpha-1 (Ta1), also designated thymalfasin in the pharmacological literature, is a naturally occurring 28-amino acid peptide originally isolated from thymosin fraction 5 of bovine thymus tissue by Allan Goldstein and colleagues at George Washington University in 1977. The compound was identified during a systematic research program examining the biological activities of thymic peptides, a […]
Tesamorelin is a synthetic analog of endogenous growth hormone-releasing hormone (GHRH), the hypothalamic peptide responsible for stimulating growth hormone secretion from somatotroph cells of the anterior pituitary gland. The compound consists of the complete 44-amino acid sequence of human GHRH(1-44) conjugated at its N-terminus to a trans-3-hexenoic acid moiety, a structural modification that confers substantially […]
TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4 (TB4), a naturally occurring 43-amino acid protein that is found in virtually all nucleated mammalian cells and has been identified in particularly high concentrations in platelets, wound fluid, and various tissue types. The compound was isolated and studied as a means of examining the biological […]
Semaglutide is a synthetic analog of glucagon-like peptide-1 (GLP-1), an endogenous incretin hormone produced by enteroendocrine L-cells of the gastrointestinal tract in response to nutrient ingestion. The compound was developed by Novo Nordisk and first described in the scientific literature in the mid-2000s as part of a broader research program investigating long-acting GLP-1 receptor agonists […]
